“No one has previously done a large, randomized trial looking at any ablation modality in persistent atrial fibrillation patients as a first-line therapy,” Boston Scientific Chief Medical Officer ...

A multicenter Chinese trial reports that a novel asymmetric biphasic pulsed field ablation system achieved complete acute ...

Pulse Biosciences Inc.'s NANOPULSE-AF Study—initiated in April—has surpassed its enrollment midpoint, the company announced.

First-line treatment with pulsed field ablation (PFA) reduced the risk of recurrence of atrial arrhythmia among patients with persistent atrial fibrillation (Afib), the randomized AVANT GUARD trial ...

A 62-year-old woman with recurrent atrial fibrillation and hypertrophic obstructive cardiomyopathy underwent pulse field ...

Pulsed field ablation did not have superior efficacy to radiofrequency ablation in patients with drug-resistant paroxysmal (intermittent) atrial fibrillation, according to results from a late-breaking ...

Emerging pulsed field ablation systems have made a major impact in the treatment of atrial fibrillation, with major medtechs receiving international approvals in the past year as newcomers wait in the ...

Pulsed field ablation allows us to treat AFib in a way that is minimally invasive, efficient and designed to enhance both safety and recovery.” — Dr. Saumil Oza ...

It is expected that within the next 20 years that 20 million-60 million people will get atrial fibrillation, usually just called AFib. People with AFib have a five-times increased risk of stroke ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. A new heart ablation procedure being used across UCHealth ...